Introduction
Bowel disturbance following bladder reconstruction : 4
`Nerve sparing' cystectomy and substitution cystoplasty in patients of either sex - limitations and techniques : 5
Further experience with the valved S-shaped rectosigmoid pouch for continent urinary diversion : 6
Antireflux nipples versus afferent tubular ileal segment in 70 patients with a low pressure ileal reservoir. Long-term results of a prospective randomized trial : 7
Long-term follow-up of renal function in patients after undiversion or primary urinary tract reconstruction : 8
The long-term follow-up of urethroplasty for non-traumatic urethral strictures : 9
Early experience with the use of buccal mucosa for substitution urethroplasty : 10
Dilatation versus internal urethrotomy as out-patient treatment for male urethral strictures - a prospective, randomized clinical trial : 11
Clinical results of artificial sphincter in the treatment of post-prostatectomy incontinence : 12
The fate of the `modern' artificial urinary sphincter with a follow-up of more than 10 years : 13
Long-term results of the artificial urinary sphincter in 250 patients : 14
`Sling on a string'; for the surgical treatment of stress incontinence : 15
Long-term results of transabdominal urethral closure : 16
An analysis of the competence of the sphincter mechanism of the supramembranous male urethra and its reconstruction after injury : 17
Results and complications of lasertripsy for ureteric calculi using the Holmium-Yag laser : 18
An ideal energy for intracorporeal ureterolitholapaxy: an audit : 19
In situ ESWL for ureteric stones; the adverse effects of JJ stenting : 20
Laparoscopic ureterolithotomy is the treatment of choice in patients with failed endourological management : 21
Autoradiographic study of renal blood flow during ureteric obstruction : 22
Do patients with renal stones need long-term follow-up? : 23
Can terazosin (alpha-blocker) relieve acute urinary retention and obviate the need for an indwelling urethral catheter? : 26
Quantification of outflow function provides an algorithm to select patients for thermotherapy : 27
Low and high energy TUMT: the relation between de-obstruction and morbidity : 28
The Oxford laser prostatectomy trial: one-year data from a randomized controlled trial : 29
A prospective randomized trial of interstitial radiofrequency therapy (ITTP) versus transurethral resection for benign prostatic obstruction : 30
A study of factors that influence soft-tissue clearance rates during electrosurgical vaporization : 31
Robotic transurethral electrovaporization of the prostate : 32
Endoscopic laser ablation of the prostate - 2-year follow-up of 105 patients treated at one institution : 33
Laser prostatectomy: 3-years follow-up, a cause for concern : 34
12 months follow-up of transurethral needle ablation (TUNA™) : 35
The angiogenic factor, vascular endothelial growth factor, is detectable in urine and is overexpressed in the urine of patients with bladder cancer : 36
Metabolism of bladder cancer : 37
Acetylation phenotype and the risk of bladder cancer : 38
Telomerase activity in transitional cell carcinoma; its implications for non-invasive detection of bladder cancer : 39
Random mucosal biopsies in superficial bladder carcinoma-better at first-check cystoscopy? : 40
Carcinogenesis with nitrosamines and nitrites in paraplegics : 41
Epirubicin resistant bladder cancer and p53 oncogene status : 42
The effects of potassium-channel modulation using Zeneca ZD6 169 and Levcromakalim on human bladder muscle contractility : 43
The preliminary results of detrusor myomectomy for detrusor instability and hyper-reflexia : 44
Interactive multi-media computer-based patient information program for patients with incontinence : 45
3-day versus 7-day frequency/volume charts : 46
Cystitis associated with tiaprofenic acid (Surgan TM); a survey of British and Irish urologists : 47
Assessment and quality of life following clam ileocystoplasty : 48
Variations in PSA level following various urological procedures : 49
Free to total PSA ratio: a second screening test for prostate cancer : 50
Bone morphogenetic protein-6 expression correlates with metastatic prostate cancer : 51
Skeletal alkaline phosphatase in the metastatic evaluation of patients with prostate cancer : 52
The effects of combining hormonal manipulation and ionizing radiation on prostatic carcinoma cells in vitro : 53
Incidence and impact of incontinence and impotence following retropubic total prostatectomy : 54
Is transrectal ultrasonography without biopsy justifiable? : 55
Nuclear transcription factors in bladder cancer: c-myc is associated with apoptosis : 56
Is recurrent TCC derived from the same clone of cells? : 57
Does the accumulation of genetic mutations in bladder cancer precede pathological progression? : 58
The roles of interstitial collagenase and tissue inhibitor of metalloproteinases in bladder tumours : 59
Determination and reversal of resistance to intravesical epirubicin : 60
A prospective, randomized, multi-centre, phase III clinical trial of the effect of different initial therapy regimens and maintenance prophylaxis in superficial bladder cancer, using Mitomycin C : 61
Radical transurethral resection and chemotherapy in the treatment of muscle invasive bladder cancer - long-term follow-up : 62
A meticulous lymphadenectomy may improve survival in invasive bladder cancer - the influence of location of nodal metastasis : 63
Prognosis for children born with multicystic dysplastic kidneys : 64
Vesico-ureteric reflux and dysfunctional voiders: resolution rate and age at diagnosis : 65
One-stage orchidopexy for high undescended testes using low testicular vascular ligation: an alternative to the Fowler-Stephens technique : 66
Management of the intraperitoneal testis : 67
Spontaneous rupture of augmentation entero-cystoplasty in children : 68
Combined use of Mitrofanoff channel and ACE procedure for urinary and faecal incontinence : 69
The anatomy and reconstruction of the adult female genitalia in classical bladder exstrophy : 70
Comparison of various methods of repairing the symphysis pubis in bladder exstrophy by tensile testing : 71
Effect of transforming growth factor ß1 and ß2 on human prostatic epithelial proliferation in culture : 83
Normalized obstruction and contractility coefficients for detailed analysis of voiding function : 84
Wives notice `prostatism' too! : 85
A pilot study for a prostate assessment clinic for symptomatic men : 86
Urodynamic grading of obstruction can predict the outcome of transurethral prostatectomy : 87
Who needs follow-up after TURP? The telephone can help : 88
A TURP simulator - further developments : 89
Urodynamic, ultrasonographic and cystoscopic findings: correlation with irritative symptoms following laser prostatectomy : 90
Adult polycystic kidney disease can obstruct : 91
The use of capsaicin in the management of the loin pain/haematuria syndrome : 92
How safe is conservative surgery for upper urinary tract tumours? : 93
Thoraco-abdominal extra-peritoneal approach for the excision of retro-peritoneal tumours : 94
Laparoscopic extraperitoneal fibrin-glued Pyeloplasty: mediumterm results : 95
Combined antegrade-radiological and retrograde-endoscopic approach to ureteric strictures: a rendezvous procedure : 96
The long-term results of sphincterotomy in spinally injured patients : 97
The `urolume' for detrusor-sphincter dyssynergia - do the longer term results justify its continued use? : 98
Emptying the neurogenic bladder - the use of a new device : 99
A survey of urinary retention in 100 young women : 100
The effect of capsaicin on nerve densities in the human urinary bladder : 101
Neuromodulation of detrusor hyper-reflexia using functional magnetic stimulation : 102
Ambulatory urodynamics in the difficult patient : 106
Non-invasive urodynamic assessment of bladder outlet and detrusor function : 107
Efficacy and tolerance of intravesical oxybutynin for detrusor hyper-reflexia: a randomized, double-blind placebo-controlled dose-ranging study : 108
Transcutaneous neurostimulation for irritative bladder symptoms : 109
Case-directed management of urinary stress incontinence : 110
The Autocath 100TM intra-urethral incontinence device : 111
Endoscopic correction of intractable stress incontinence with uroplastique. A follow-up report : 112
Cimetidine in the treatment of interstitial cystitis : 113
Urogenital criteria in Parkinsonism : 114
Giggle incontinence - urodynamic findings and long-term follow-up : 115
Urological manifestations of human immuno-deficiency virus (HIV): observations in Africa : 116
Commencing alpha blockers for patients with cardiovascular disease - recommendations for safe prescribing : 117
Suprapubic and transurethral pressure flow study in the diagnosis of bladder outflow obstruction : 118
Does an increase in nocturnal post-micturation residual volumes contribute to nocturnal frequency in men with bladder outlet obstruction due to BPH? : 119
Anti-platelet and non-steroidal anti-inflammatory drugs in transurethral surgery of the prostate and bleeding complications : 120
Does resection size at TURP affect outcome? : 121
Routine post-operative haemoglobin testing is unnecessary following TURP : 122
Cardiovascular effects of endoscopic laser ablation of the prostate : 123
Results of a European multicentre study evaluating the efficacy of an interstitial laser coagulation device : 124
Prostatic thermotherapy using Thermex II; 142 cases followed to 3 years : 125
The bulbar elongation advancement procedure-BEAM-for hypospadiac neo-meatoplasty : 126
An audit of urethral stricture management in Lothian : 127
Prostacyclin and cyclic AMP synthesis by the penis of the diabetic rabbit : 128
Primary retro-peritoneal teratoma in men; treated with chemotherapy followed by excision of the residual mass : 129
A conservative approach to bilateral testicular germ cell carcinoma : 130
Human vas: a model for the α 1 a adrenoceptor : 131
The incidence of cystic fibrosis gene mutations in patients with congenital bilateral absence of the vas deferens (CBAVD) in Scotland : 132
Action down the Y : 133
Epididymectomy is useful in the management of post-vasectomy scrotal pain : 134
Open versus closed epididymal sperm retrieval in men with secondarily obstructed vasal systems : 135
The nurse-led prostate clinic : 136
The selection of men with moderate lower urinary tract symptoms (LUTS) for non-surgical treatment in the community: is the urologist necessary? : 137
Clinical nurse specialist run pre-admission clinics - an effective, patient-friendly alternative to clerking by medical staff : 138
Nurse-directed impotence therapy: improved compliance and understanding : 139
Tele-cystoscopy: the nurse practitioners' procedure : 140
Further developments in urological specialist nursing : 141
Study comparing traditional medical and nurse-led clerking and shared-admission clerking : 142
A prospective, randomized, double-blind study to compare lignocaine gel and plain lubricating gel in relieving pain during flexible cystoscopy : 143
A 5-year review of modern methods of sperm retrieval in the presence of inoperable obstructive azoospermia : 155
PESA with ICSI: simplified sperm retrieval and microinjection in patients with azoospermia : 156
Effects of a permeation-enhanced testosterone transdermal system on prostate parameters in previously treated or untreated hypogonadal males : 157
The role of orchidectomy in the management of postpubertal cryptorchidism : 158
Varicocele embolization versus ligation: venographic findings and causes of failure : 159
The World Health Organization varicocele trial : 160
There is significant sexual dysfunction following TURP : 161
Distal penile fibrosis following intracavernosal prostaglandin E1 injections : 162
Alterations in endothelin B receptor-binding sites on the cavernosal tissue of diabetic rabbits : 163
Should we offer inflatable penile prosthesis to all patients?: a comparative review of 104 patients with malleable or inflatable prostheses : 164
Late recurrence of germ cell cancer: the need for more active surveillance and early surgery : 165
The critical role of surgery following chemotherapy for para-aortic nodal masses in non-seminomatous germ-cell tumours : 166
When contralateral testis biopsy is essential in testicular cancer : 167
Keratinocyte growth factor is a paracrine agent in human prostate cancer : 168
Over-expression of androgen-induced growth factor in human prostate cancer : 169
Heregulin as a potential autocrine growth factor and a poor prognostic indicator in prostate cancer : 170
Characterization of voltage sensitive Na+ channels in PC-3 cells by patch clamping is consistent with findings on immunohistochemistry, western blotting and FACS analysis : 171
Expression of membrane-type matrix metalloproteinase in malignant prostate compared with paired benign tissue and specimens of BPH : 172
Expression of three candidate tumour suppressor genes on chromosome 5q, α-catenin, APC and MCC, in prostate cancer : 173
The National Comparative Urological Audit Service - what has this achieved? : 177
Written consent is haphazard for minor urological procedures : 178
Are we doing too much day surgery? : 179
Is urological practice evidence-based? : 180
Teleconferencing in urological practice. A pilot study : 181
POSSUM-how to do it in urology : 182
The use of the Haemonetic™ cell saver in major urological surgery : 183
Diuresis renography: which radiopharmaceutical? : 184
Screening for bacteriuria in patients with upper urinary tract calculi : 185
Allopurinol improves renal blood flow following release of ureteric obstruction : 186
Medium-term result of the ENDOBRST procedure for pelviureteric junction : 187
Reliable upper urinary tract surveillance in children with spina bifida : 188
Antegrade stenting for iatrogenic ureteric injury: long-term results : 189
Influence of biomaterial surface characteristics on encrustation of ureteric stents : 190
Modified laparoscopic colposuspension : 191
Neural network analysis of prognostic markers in prostate cancer : 196
Two new tumour suppressor genes on chromosome 8p in prostate cancer : 197
Correlation of lymphocytic infiltration with HLA class I expression: evidence of immune regulation in prostate cancer : 198
Quantitative assessment of prognostic factors in prostate cancer patients at initial diagnosis: the design of a prognostic index score : 199
The clinical results of radical prostatectomy : 200
Can incontinence following radical prostatectomy be prevented? : 201
Is radical prostatectomy indicated in incidental prostatic cancer? : 202
Conventional radiation therapy for the treatment of prostate cancer: analysis of long-term results : 203
Hormone therapy in advanced prostate cancer - report of the Medical Research Council `immediate' versus `deferred' treatment study : 204
Prostatic growth stimulation and binding by human bone marrow: mechanisms of metastatic spread in prostate cancer : 205
Antegrade stenting in ureteric obstruction due to carcinoma of prostate. Is it worthwhile? : 206